NCT07729553Not yet recruiting
Vitamin D Status and Lipid Profile in Obese Adults With Type 2 Diabetes
Association Between Serum 25-Hydroxyvitamin D Status and Lipid Profile Among Obese Adults With Type 2 Diabetes Mellitus: A Cross-Sectional Study
Source: ClinicalTrials.gov · Last updated 27 Jul 2026
Brief summary (registry, in English)
This prospective, single-center, cross-sectional observational study aims to evaluate the association between serum 25-hydroxyvitamin D concentrations and lipid profile parameters among adults with obesity and established type 2 diabetes mellitus. A total of 160 participants will be recruited from an outpatient diabetes clinic in Cairo, Egypt. Each participant will undergo a single clinical, anthropometric, and laboratory assessment. No intervention or treatment will be assigned by the investigators.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 22 Jul 2026
- Start date
- 25 Jul 2026
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Sinai University
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT07729553
What you commit to
- Study type: Observational
- Planned participants: 150
- From 25 Jul 2026 to the primary completion date, 30 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of medications or supplements that substantially alter vitamin D metabolism (when applicable).
Other illness
- Type 1 diabetes mellitus.
- Known chronic kidney disease.
- Chronic liver disease.
- Active malignancy.
- Acute infection or inflammatory disease.
- Conditions affecting gastrointestinal absorption.
Other
- Pregnancy.
Who the study is looking for
- Adults aged 18 years or older.
- Established diagnosis of type 2 diabetes mellitus (T2DM) according to standard diagnostic criteria.
- Obesity based on body mass index (BMI) criteria.
- Availability of serum 25-hydroxyvitamin D \[25(OH)D\] measurement.
- Availability of lipid profile and glycemic laboratory parameters.
- Ability and willingness to provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.